[11]“Soliman, Nahed A, and Shaimaa M Yussif. “Ki-67 as a prognostic marker according to breast cancer molecular subtype.” Cancer biology & medicine vol. 13,4 (2016): 496-504. doi:10.20892/j.issn.2095-3941.2016....
综合国内外研究可发现,不同的文献中,Ki-67的临界值从10%至50%不等;此外,仍有很多问题有待于进一步解答,如乳腺癌各分子亚型Ki-67表达水平下降程度是否一致、Ki-67表达水平下降的时间、早期观察到 Ki-67 表达水平下降的患者与多周期化疗后才下降的患者远期预后是否有差异等。
[5]Correlation between expression of LRP16,Ki-67 andEGFR and breast cancer clinical pathologic factors and prognosis.Eur Rev Med PharmacolSci.2017。 [6]J Surg Oncol.2016Jan;113(1):46-54.Ki-67--An unsuitable marker of gastric cancer prognosisunmasks intratumoral heterogeneit。 [7]Horm Cancer....
[5]Correlation between expression of LRP16,Ki-67 andEGFR and breast cancer clinical pathologic factors and prognosis.Eur Rev Med PharmacolSci.2017。 [6]J Surg Oncol.2016Jan;113(1):46-54.Ki-67--An unsuitable mark...
production of a mouse monoclonal antibody reactive with a human nuclearantigen associated with cellproliferationjcancer, 1983.31 6、(1): 13一20.2 urruticoechea a, smith ie, dowsett m, et a 1.proliferationmarker ki-67 in early breastcancerjclin oncol, 2005, 23 (28): 7212-7220.3 evandro ...
Ki 67高表达可作为乳腺癌的不良预后因素,其与肿瘤的发展、转移和预后高度相关。 【关键词】 乳腺肿瘤;Ki 67抗原;预后CellproliferationmarkerKi 67andbreastcancer JIAMing,HUBo fei,WEISu ju.DepartmentofOncology,FourthHospitalofHebeiMedicalUniversity,Shijiazhuang050011,ChinaCorrespondingauthor:WEISu ju,E mail:jusajoa...
Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients. Breast 2009; 18: 135-141.Wiesner FG, Magener A, Fasching PA, Wesse J et al. Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients. The Breast 2009; 18(2): ...
1.Correlation between expression of LRP16, Ki67 andEGFR and breast cancer clinical pathologic factors and prognosis.Eur Rev Med PharmacolSci.2017 2.J Surg Oncol. 2016Jan;113(1):46-54. Ki67--An unsuitable marker of gastric cancer prognosisunmasks intratumoral heterogeneity ...
Prognostic Marker Most notably, the Ki-67 index has growing importance in breast cancer. This highly heterogeneous disease is characterized by the presence of discrete molecular subtypes with distinct clinical behaviors that can be classified according to gene expression signatures.16 Findings from numer...
1.Correlation between expression of LRP16, Ki67 andEGFR and breast cancer clinical pathologic factors and prognosis.Eur Rev Med PharmacolSci.2017 2.J Surg Oncol. 2016Jan;113(1):46-54. Ki67--An unsuitable marker of gastric cancer prognosisunmasks intratumoral heterogeneity ...